American Oncology Network (AONC) Competitors $4.64 +0.15 (+3.34%) (As of 12/20/2024 04:34 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends AONC vs. ACONW, DHACW, LFMDP, OTRKP, PIIIW, TALKW, TOIIW, NTRA, FMS, and HIMSShould you be buying American Oncology Network stock or one of its competitors? The main competitors of American Oncology Network include Aclarion (ACONW), Digital Health Acquisition (DHACW), LifeMD (LFMDP), Ontrak (OTRKP), P3 Health Partners (PIIIW), Talkspace (TALKW), Oncology Institute (TOIIW), Natera (NTRA), Fresenius Medical Care (FMS), and Hims & Hers Health (HIMS). These companies are all part of the "healthcare" industry. American Oncology Network vs. Aclarion Digital Health Acquisition LifeMD Ontrak P3 Health Partners Talkspace Oncology Institute Natera Fresenius Medical Care Hims & Hers Health Aclarion (NASDAQ:ACONW) and American Oncology Network (NASDAQ:AONC) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, community ranking, risk, media sentiment, analyst recommendations, earnings, valuation, dividends and institutional ownership. Is ACONW or AONC more profitable? Company Net Margins Return on Equity Return on Assets AclarionN/A N/A N/A American Oncology Network N/A N/A N/A Does the MarketBeat Community prefer ACONW or AONC? Aclarion and American Oncology Network both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformAclarionN/AN/AAmerican Oncology NetworkN/AN/A Which has higher earnings & valuation, ACONW or AONC? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAclarion$49.29KN/AN/AN/AN/AAmerican Oncology Network$1.34BN/AN/AN/AN/A Does the media refer more to ACONW or AONC? In the previous week, American Oncology Network had 3 more articles in the media than Aclarion. MarketBeat recorded 3 mentions for American Oncology Network and 0 mentions for Aclarion. Aclarion's average media sentiment score of 0.00 equaled American Oncology Network'saverage media sentiment score. Company Overall Sentiment Aclarion Neutral American Oncology Network Neutral SummaryAmerican Oncology Network beats Aclarion on 2 of the 2 factors compared between the two stocks. Ad Crypto 101 MediaThe #1 Coin for November 2024Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide… You can get access to the report by clicking here now… Get American Oncology Network News Delivered to You Automatically Sign up to receive the latest news and ratings for AONC and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AONC vs. The Competition Export to ExcelMetricAmerican Oncology NetworkMedical Care Facilities IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$1.45B$5.14B$9.08BDividend YieldN/A3.79%5.09%4.23%P/E RatioN/A209.5590.1317.20Price / SalesN/A54.381,117.09117.05Price / CashN/A13.4543.1037.85Price / BookN/A2.314.784.78Net IncomeN/A$52.03M$120.31M$225.60M7 Day Performance1.75%-1.00%-1.92%-1.23%1 Month Performance11.14%1.99%13.65%0.46%1 Year Performance-24.06%12.94%28.34%15.24% American Oncology Network Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AONCAmerican Oncology NetworkN/A$4.64+3.3%N/A-22.5%$0.00$1.34B0.001,520News CoverageACONWAclarionN/A$0.03-23.8%N/A-36.1%$0.00$49,289.000.007Positive NewsDHACWDigital Health AcquisitionN/A$0.06flatN/AN/A$0.00N/A0.00N/ALFMDPLifeMDN/A$22.500.0%N/A+17.1%$0.00$193.06M0.00230OTRKPOntrakN/A$0.28-3.5%N/A-57.6%$0.00$10.84M0.00250Gap DownPIIIWP3 Health PartnersN/A$0.01flatN/AN/A$0.00$1.48B0.00500Positive NewsTALKWTalkspaceN/A$0.12-14.2%N/A+7.1%$0.00$181.29M0.00500Gap DownTOIIWOncology InstituteN/A$0.01flatN/A-95.0%$0.00$378.93M0.00660Positive NewsNTRANatera2.0775 of 5 stars$170.80+2.6%$152.67-10.6%+168.5%$22.55B$1.53B-97.053,293Positive NewsGap DownFMSFresenius Medical Care3.4964 of 5 stars$23.82+0.7%$24.30+2.0%+8.6%$13.98B$19.24B19.691,358News CoveragePositive NewsHIMSHims & Hers Health3.3845 of 5 stars$31.24+4.0%$21.43-31.4%+204.8%$6.82B$872M70.991,046Analyst ForecastInsider TradeNews Coverage Related Companies and Tools Related Companies ACONW Alternatives DHACW Alternatives LFMDP Alternatives OTRKP Alternatives PIIIW Alternatives TALKW Alternatives TOIIW Alternatives NTRA Alternatives FMS Alternatives HIMS Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:AONC) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding American Oncology Network, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share American Oncology Network With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
